Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
M.D. Anderson Cancer Center
University of California, Davis
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Blue Earth Therapeutics Ltd
Cedars-Sinai Medical Center
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
DL Analytics
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
AgonOx, Inc.
Memorial Sloan Kettering Cancer Center
RenJi Hospital
M.D. Anderson Cancer Center
Eli Lilly and Company
The Netherlands Cancer Institute
Queen Mary University of London
Pathos AI, Inc.
University of California, San Francisco
British Columbia Cancer Agency
Dana-Farber Cancer Institute
Milton S. Hershey Medical Center
Ottawa Hospital Research Institute
Marengo Therapeutics, Inc.
Lipac Oncology LLC
Eli Lilly and Company
University of California, Irvine
Advanced Accelerator Applications
Endocyte